![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 14/605 | (2006.01) |
C07K 14/605 | (2013.01) | ||
A61K 38/26 | (2006.01) | ||
A61K 38/26 | (2013.01) | ||
A61K 38/00 | (2006.01) | ||
A61K 9/0019 | (2013.01) | ||
A61K 9/08 | (2013.01) | ||
A61K 47/10 | (2013.01) | ||
A61K 47/183 | (2013.01) | ||
A61K 47/26 | (2013.01) | ||
A61K 47/12 | (2013.01) |
(11) | Number of the document | 3856767 |
(13) | Kind of document | T |
(96) | European patent application number | 19779866.3 |
Date of filing the European patent application | 2019-09-27 | |
(97) | Date of publication of the European application | 2021-08-04 |
(45) | Date of publication and mention of the grant of the patent | 2024-03-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2019/076304 |
Date | 2019-09-27 |
(87) | Number | WO 2020/065063 |
Date | 2020-04-02 |
(30) | Number | Date | Country code |
18197750 | 2018-09-28 | EP |
(72) |
PARSHAD, Henrik Rajesh Kumar , DK
GIEHM, Lise , DK
MELANDER, Claes , DK
|
(73) |
Zealand Pharma A/S ,
Sydmarken 11, 2860 Søborg,
DK
|
(54) | FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES |
FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES |